Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mother's Milk Is Best, commonly branded as MMIB, is a private U.S. medical device company developing a human milk concentration device for preterm infants in neonatal intensive care settings. Its technology is designed to concentrate a mother's own milk at the bedside by passively removing water, with the goal of improving nutrient density while preserving the benefits of human milk. The company focuses on neonatal nutrition and aims to reduce dependence on cow milk-based fortifiers for premature babies. MMIB appears to be an early-stage, venture- and grant-backed healthcare company rather than a therapeutics developer, with commercialization activity centered on device development for NICU feeding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mothers Milk.